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Research
Bisphenol A (BPA) has been widely used in 
the manufacture of various consumer prod-
ucts and is one of the highest-volume chemi-
cals produced worldwide. Hydrolysis of BPA 
under heat, acidic, or basic conditions leads to 
the release of BPA to the environment and the 
potential exposure to human beings. Indeed, 
available data from biomonitoring studies 
clearly indicate that the general population is 
exposed to BPA and is at risk from internal 
exposure to unconjugated BPA (Vandenberg 
et al. 2010). The core structure of BPA resem-
bles that of natural 17β-estradiol (E2), and 
rodent and in vitro studies have demonstrated 
its endocrine-disruptive effects on reproduc-
tive and developmental tissues (Richter et al. 
2007; Wetherill et al. 2007). However, there 
is an ongoing debate about whether BPA poses 
a hazard to human health at environmental 
exposure levels, because many xeno  estrogens 
have weak binding ability to the classical estro-
gen receptors (ERs) 1,000–2,000 times lower 
than that of E2 at the lower pico  molar or nano-
molar concentrations (Bonefeld-Jørgensen et al. 
2001). Recently, accumulating evidence has 
demon  strated that some xeno  estrogens exert 
biological effects at levels lower than those pres-
ently considered safe. In vivo studies have docu-
mented that pre  natal and neo  natal exposure of 
male rats to low doses of BPA causes significant 
impairments in testicu  lar develop  ment and 
spermato  genesis (Salian et al. 2011), suggesting 
a long-term and lasting impact of low-dose 
BPA on the offspring fertility during adulthood. 
Furthermore, BPA at environmentally relevant 
concentrations has been found to stimulate 
proliferation of human testicular JKT-1 cells 
through a non  genomic action independent of 
classical ERs (Bouskine et al. 2009). However, 
the exact mechanisms are still unclear.
In the present study, we used mouse 
spermato  gonial GC-1 cells as an experi  mental 
model because these cells display specific fea-
tures common to type B spermato  gonia and 
early spermato  cytes (Bellvé et al. 1977). In 
addition, GC-1 cells express G protein–coupled 
receptor 30 (GPR30), which mediates a rapid 
xeno  estrogen-activated pathway in pre  meiotic 
germ cells, among which spermato  gonia rep-
resent the most important cell population. 
Thus, these cell lines might be useful to inves-
tigate the role of GPR30 in the proliferation- 
promoting effects stimulated by BPA.
In the present study, we examined whether 
low concentrations of BPA (10–12 to 10–7 M), 
which are environmentally relevant, can stimu-
late proliferation of GC-1 cells via such a non-
genomic action and, if so, whether GPR30 or 
its combination with ER-α is involved in the 
proliferation.
Materials and Methods
Reagents. All chemicals were of reagent grade or 
better and were purchased from Sigma Chemical 
Co. (St. Louis, MO, USA) unless otherwise 
noted. We purchased anti  bodies against 
GPR30, ER-α, and glycerald  ehyde 3-phosphate 
dehydrogenase (GAPDH) from Cell Signaling 
Technology Inc. (Beverly, MA, USA) and 
horseradish peroxidase-conjugated secondary 
antibody from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA). All compounds were 
solubilized in dimethyl sulfoxide (DMSO) 
except E2 and PD98059 [2-(2-amino-3-
methoxyphenyl)-4H-1-benzopyran-4-one], 
which were dissolved in ethanol. Although the 
quality of compounds was guaranteed by manu-
facturers, we confirmed quality by analyzing the 
key regents and solutions, such as BPA, before 
the experiments. We used steroid-free medium 
containing DMSO as the control. 
Cell treatments. GC-1 and SkBr3 cells 
were cultured in phenol red–free Dulbecco’s 
modified Eagle medium (DMEM)/F-12 (1:1) 
and RPMI 1640 growth medium, respectively, 
which was supplemented with 10% charcoal-
stripped fetal bovine serum, 1% glutamine, 
and 1% penicillin/streptomycin. Cells were 
maintained in growth medium for 48 hr and 
then switched to serum-free medium the day 
before immuno  blot and reverse-transcription 
polymerase chain reaction (RT-PCR) experi-
ments. For cell proliferation experiments, we 
used a cell density of 103 cells per well as a stat-
ing point. Both the plastic items used for the 
experiments and the water used to prepare the 
reagents were pretreated by enhanced sono-
chemical degradation to reduce any potential 
background BPA (Pétrier et al. 2010). 
MTT [3-(4,5-dimethyl-thiazol-2-yl)-2,5-
diphenyl-tetrazolium bromide] assay. Cell 
viability was determined using an MTT assay. 
Briefly, at the end of treatment, 100 µL MTT 
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Ba c k g r o u n d: Bisphenol A (BPA) is one of the most prevalent chemicals in daily-use materials; 
therefore, human exposure to BPA is ubiquitous. The estrogenicity of BPA is generally mediated 
by nuclear estrogen receptors (ERs). However, low concentrations of BPA stimulate seminoma cell 
proliferation by an uncertain mechanism that does not involve activation of ERs.
oB j e c t i v e: We investigated the possible promoting effects of low-concentration BPA and the pos-
sible mechanism(s) using the murine ER-β negative spermatogonial GC-1 cell line. 
Me t h o d s  a n d r e s u l t s: Using the specific signaling inhibitor, BPA at test concentrations ranging 
from 10–10 to 10–8 M markedly induced proliferation of GC-1 cells by activating both cGMP-
dependent protein kinase (PKG) and epidermal growth factor receptor (EGFR) extra  cellular regu-
lated kinase (ERK) pathways. BPA stimulated a rapid (15-min) phosphorylation of the transcription 
factor cAMP response element binding protein (CREB) and the cell cycle regulator retinoblastoma 
protein (Rb). Interestingly, ER-α phosphorylation is involved in the proliferation, whereas BPA does 
not directly transactivate ER-α in gene reporter assays. Using specific agonists and gene silencing, 
we further observed that BPA mediates the proliferation and fos gene expression of GC-1 cells by 
G protein–coupled receptor 30 (GPR30) and ER-α.
co n c l u s i o n s: Our data suggest that low concentrations of BPA activate the PKG and EGFR/ERK/
c-fos pathways through a cross-talk between GPR30 and ER-α, which in turn stimulates GC-1 cell 
proliferation. The present study provides a novel insight regarding the potential role of GPR30 and 
ER-α in mediating the proliferative effects of BPA in male germ cells.
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(5 mg/mL in 1 M phosphate-buffered saline, 
pH 7.6) was added to each well of 96-well 
plates and the plates were incubated for 2 hr 
at 37°C in 5% CO2/95% air. Optical den-
sity (OD) was measured at 570 nm with a 
microplate reader. 
[3H]-thymidine incorporation analysis. 
We evaluated [3H]-thymidine incorpora-
tion after 6 hr incubation with 1 µCi [3H]-
thymidine per well. Cells were washed once 
with 10% trichloro  acetic acid, twice with 5% 
trichloro  acetic acid, then lysed in 1 mL 0.1 M 
NaOH at 37°C for 30 min. The total suspen-
sion was added to 10 mL optifluor fluid and 
counted in a scintillation counter.
Caspase 3 activity assay. We used the 
caspase 3 activity assay, which involves spectro-
photometric detection of the chromophore 
p-nitroanilide after cleavage from the substrate 
Ac-DEVD-p-nitroanilide. The method has 
been described previously (Sheng et al. 2008).
Effect of BPA on G protein–coupled recep-
tor (GPCR), cGMP-dependent protein kinase 
(PKG), and epidermal growth factor receptor–
extra  cellular regulated kinase (EFGR-ERK) 
pathways. We examined BPA’s ability to acti-
vate different downstream signaling transduc-
tion pathways (kinases) by pretreating GC-1 
cells with the PKG inhibitor KT5823, the 
ERK inhibitor PD98059, the Gαi/Gαq 
inhibitor pertussis toxin (PTX), the Src inhibi-
tor PP2, the EGFR inhibitor AG-1478, the 
cAMP-dependent protein kinase (PKA) 
inhibitor H89, and the Gαs inhibitor NF449 
before 12-hr exposure to 10–9 M BPA, a 
concentration that provided maximum cell 
prolifera  tion and then evaluated cell viability 
using the MTT assay. 
Real-time RT-PCR. Real-time RT-PCR 
methods have been described previously 
(Sirianni et al. 2008). Briefly, we obtained 
total RNA from cells using an RNA isolation 
kit (Invitrogen, Burlington, Ontario, Canada). 
After total RNA was spectrophotometrically 
quantified, we performed reverse transcrip-
tion and PCR amplification using a One-Step 
Brilliant SYBR Green quantitative RT-PCR 
master mix kit (Bio-Rad, Hercules, CA, USA) 
in a single reaction following the manufac-
turer’s instructions. cDNA conversion, ampli-
fication, and data analysis were performed 
using an Mx3000P real-time PCR system 
computerized cycler (Bio-Rad). Primers for 
the amplification were based on published 
sequences for mouse fos. The nucleo  tide 
sequences of the primers were as follows: for-
ward, 5´-GAG GAG GGA GCT GAC AGA 
TAC ACT-3´ and reverse, 5´-GAT TGG 
CAA TCT CAG TCT GCA A-3´.
Western blot analysis. Methods for 
Western blotting have been described in detail 
previously (Sheng et al. 2008). For protein 
extraction, treated cells were lysed in ice-cold 
lysis buffer, and the protein concentration was 
determined using a BCA (bicinchoninic acid) 
Protein Assay Kit (Invitrogen). Protein was 
separated using SDS-PAGE and then trans-
ferred onto a nitro  cellulose membrane, which 
was subsequently probed with the following 
primary antibodies: anti-GPR30 (1:1,000), 
anti-ER-α (1:500), anti-p-Ser118-ER-α 
(1:500), anti-p-response element binding pro-
tein (CREB) (1:1,000), anti-p-retinoblastoma 
protein (Rb) (1:1,000), and anti-GAPDH as 
an internal control. After incubation, blots were 
incubated with the appropriate secon  dary anti-
bodies conjugated to horse  radish peroxidase. 
The bands were revealed by enhanced chemilu-
minescence using the ECL (enhanced chemilu-
minescence) commercial kit (Invitrogen). 
Plasmids. Plasmids used were described 
previously by Albanito et al. (2008a). Briefly, 
we used EREtkLuc for ER and GK1 for yeast 
transcription factor Gal4 fusion proteins. 
EREtkLuc (XETL) contains the estrogen 
response element (ERE), the herpes simplex 
virus thymidine kinase promoter region, the 
firefly luciferase coding sequence, and the SV40 
splice and polyadenylation sites. Gal4 chimeras 
Gal-ER-α and Gal-ER-β were expressed from 
plasmids GAL 93ER (G) and GAL ER-β, 
respectively. They were constructed by transfer-
ring the coding sequences for the hormone-
binding domain (HBD) of ER-α from HEG0 
and for the ER-β HBD from plasmid pCMV5-
Her-β into the pSCTEVGal93. The Renilla 
luciferase expression vector pRL-TK served as a 
transfection standard.
Transfection and luciferase assays. We per-
formed transfection and luciferase assays as 
described by Albanito et al. (2008a). Briefly, 
medium was replaced with phenol red–free 
DMEM/F-12 or RPMI 1640, and transfec-
tion was performed using FuGENE 6 Reagent 
(Roche Diagnostics, Mannheim, Germany) as 
recommended by the manufacturer. After the 
cells were subjected to the various treatment 
regimens, luciferase activity was measured with 
the Dual Luciferase Kit (Promega, Madison, 
WI, USA) according to the manufacturer’s 
recommendations. Firefly luciferase values 
were normalized to the internal transfection 
control provided by Renilla luciferase activ-
ity. The normalized relative light unit values 
obtained from cells treated with vehicle were 
considered 1-fold induction, and the activity 
induced by the various treatments was then 
calculated based on the control reference.
Antisense oligodeoxynucleotide experiments. 
We purchased antisense (AS) oligo  nucleo-
tides (AS-ODNs) from MWG (Florence, 
Italy). The ODNs used were 5´-TGG 
AGT AGT CGC ATC CAT-3´ for Gpr30; 
5´-GACCATGACCATGACCCT-3´ for Ers‑1, 
and 5´-GATCTCAGCACGGCAAAT-3´ 
for the scrambled control. For AS experi-
ments, 200 nM of the indicated ODN was 
transfected for 5–6 hr before treatment using 
Lipofectamine LTX (1:3; Invitrogen) accord-
ing to manufacturer’s instructions. Cells were 
Figure 1. Twelve-hour exposure to low concentrations of BPA stimulated proliferation of GC-1 cells 
through activation of the GPCR, PKG, and EFGR-ERK pathways, as determined by the MTT assay (A) and by 
[3H]-thymidine incorporation (B), as described in “Materials and Methods.” (C) Viability of cells exposed to 
10–9 M BPA for 12 hr with or without pretreatment with H89, KT5823, PD98059, NF449, PTX, PP2, or AG1478 
(inhibitors of PKA, PKG, MAPK, Gαs, Gαi/ Gαq, Src, and EFGR, respectively). Values shown for A–C are the 
percentage change above the control (mean ± SE), with the control set as 1; results represent three inde-
pendent experiments performed in triplicate. 
*p < 0.05, compared with control. **p < 0.05, compared with 10–12, 10–11, 10–7, 10–6, or 10–5 M BPA. #p < 0.05, compared with 
10–9 M BPA alone. 
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maintained in medium containing the trans-
fection mix for 36 hr before being treated for 
5 min and then lysed and used for Western 
blot analy  sis. For proliferation experiments, 
cells were maintained in medium containing 
the transfection mix for 24 hr, and medium 
was then replaced for the treatment.
Statistical analysis. All data were expressed 
as mean ± SE. We used the Student’s t-test 
for comparison of two groups in all the 
experiments. We considered differences with 
p-values < 0.05 at both tails to be statistically 
significant. All statistical analyses were per-
formed using the SPSS software for Windows, 
Release 11.5 (SPSS, Chicago, IL, USA).
Results
Very low concentrations of BPA stimulate 
GC-1 cell proliferation. GC-1 cells were 
exposed to BPA (10–12 to 10–5 M) for 12 hr, 
and cell proliferation was examined by MTT 
assay. BPA induced poliferation in an inverse 
U-shaped concentration-independent man-
ner, with a weak promotion at 10–7 M and 
10–11 M (23.56% and 16.64%, respectively) 
and the maximal effect around 10–10 to 10–8 M 
(46.28%, 48.81%, and 47.82%, respectively) 
[Figure 1A; see also Supplemental Material, 
Figure 1 (http://dx.doi.org/doi:10.1289/
ehp.1103781)]. These results demonstrate that 
GC-1 cell proliferation is stimulated by BPA 
at very low concentrations. However, another 
interpretation of this proliferative effect is that 
BPA suppressed apoptotic regulating genes 
or promoted their anti  apoptotic counter-
parts. However, we ruled out this possibility 
because BPA did not inhibit caspase 3, the 
final effector of apoptosis rela  tive to controls 
(see Supplemental Material, Figure 2). Thus, 
BPA presumably does not enhance cell survival 
by obstructing normal apoptotic mechanisms.
In addition, a [3H]-thymidine incor-
poration assay performed to corroborate 
data obtained with the MTT assay yielded 
results comparable with the viability assay 
[Figure 1B; see also Supplemental Material, 
Figure 3 (http://dx.doi.org/doi:10.1289/
ehp.1103781)], thereby supporting the notion 
that very low concentrations of BPA signifi-
cantly stimulate proliferation of GC-1 cells.
BPA promotes GC-1 cell proliferation 
through activating both GPCR, PKG, and 
EFGR-ERK pathways. Through activating 
different downstream signaling transduction 
pathways (kinases), xeno  estrogens fine-tune 
cell proliferation or apoptosis (Bulayeva and 
Watson 2004). As shown in Figure 1C, the 
PKG inhibitor KT5823, the ERK inhibitor 
PD98059, the Gαi/Gαq inhibitor pertussis 
toxin (PTX), the Src inhibitor PP2, and the 
EGFR inhibitor AG-1478 prevented GC-1 
proliferation by 10–9 M BPA, a concentra-
tion that provided maximum cell prolifera-
tion, whereas the PKA inhibitor H89 and the 
Gαs inhibitor NF449 did not, suggesting that 
both GPCR, PKG, and EGFR-ERK, but not 
PKA signaling pathways, were involved in 
proliferation stimulation by BPA.
BPA rapidly stimulates the phosphoryla-
tion of both transcription factor CREB and 
nuclear factor Rb in GC-1 cells. An earlier 
study revealed that the transcription factor 
CREB and the nuclear factor Rb partici-
pate in the regulation of gene transcription 
(Mayr and Montminy 2001). This regula-
tion is related to the stage of the cell cycle 
and the phosphorylation induced by a variety 
of protein kinases, including PKG and ERK 
(Coulon et al. 2010; Mayr and Montminy 
2001; Shaywitz and Greenberg 1999). 
Consequently, we wanted to determine if the 
well-recognized stimulus-induced transcrip-
tion factor CREB and the cell cycle regulator 
Rb can be rapidly activated by BPA in a non-
genomic manner. As shown in Figure 2, BPA 
exposure led to rapid (15 min) phosphoryla-
tion (activation) of CREB and Rb in GC-1 
cells, which was dependent on ERK and PKG, 
as both PD98059 and PTX completely abol-
ished this CREB and Rb   phosphorylation.
BPA-induced proliferation of GC-1 cells 
is involved in activation of classical nuclear 
ER-α. BPA-stimulated proliferation was simi-
lar to that caused by E2-bovine serum albu-
min (BSA), an impermeable E2 conjugate 
[see Supplemental Material, Figure 4 (http://
dx.doi.org/doi:10.1289/ehp.1103781)]. 
However, E2-BSA plus BPA induced an 
effect equivalent to those of E2-BSA of BPA 
alone, indicating a lack of synergistic or 
antagonistic effect and likely a convergence 
in the activated pathways. It should be noted 
that the combination of BPA and E2 signifi-
cantly promoted the proliferative effects of 
E2, suggesting that ER-α may play a role in 
the stimulation in GC-1 cells by by BPA (see 
Supplemental Material, Figure 4). Predictably, 
the ER antagonist ICI signifi  cantly counter-
acted the proliferative effects of E2 and BPA, 
but not E2-BSA, on GC-1 cells, indicating 
a classical nuclear ER-α–dependent mecha-
nism, because GC-1 cells express ER-α but 
not ER-β. Additionally, ER-α has an apparent 
intra  cyto  plasmic localization without any evi-
dent membrane location (Sirianni et al. 2008). 
The above results demonstrated that the prolif-
erative effects by BPA in GC-1 cells were likely 
dependent on both the classical ER-α and the 
GPCR-EFGR-ERK pathways.
BPA does not directly activate ER-α in 
GC-1 cells. Based on the finding that ER-α 
was involved with BPA-induced proliferation 
in GC-1 cells, we further employed transfec-
tion assays to assess whether BPA directly 
activated ER-α. As shown in Figure 3A, expo-
sure of the GC-1 cells to 10–9 M E2 strongly 
stimulated ER-α transactivation through a 
transiently transfected ER reporter gene 
but was abolished in the presence of 10 µM 
ICI. In contrast, BPA at ≥ 10–9 M (data not 
shown) failed to induce luciferase expression 
or to block that observed on addition of E2. 
Moreover, BPA did not activate an expres-
sion vector encoding ER-α transiently trans-
fected in ER-negative SkBr3 breast cancer cell 
(Figure 3B). In another heterologous system, 
Figure 2. BPA rapidly induced protein expression of both phosphorylated CREB (p-CREB) and phosphorylated 
RB (p-Rb) in GC-1 cells by activating the PKG and ERK pathways. (A) Western blot analysis of cells treated 
with 10–9 M BPA for 5–90 min with or without pretreatment with PD98059 or PTX; GAPDH was used as inter-
nal control to ensure that equal amounts of protein were loaded in each lane. Data represent similar results 
from three independent experiments. (B) Bands from three experiments quantified by densitometry, with 
results (mean ± SE) normalized to GAPDH expression in each sample. 
*p < 0.05, compared with control (time 0). **p < 0.05, compared with time 90 min. 
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chimeric proteins consisting of the DNA bind-
ing domain of the yeast transcription factor 
Gal4 and the ER-α or ER-β HBD transiently 
transfected in SkBr3 cells were strongly acti-
vated by E2 but not by BPA (Figure 3C,D), 
further corroborating the aforementioned 
results. These data suggested that BPA failed 
to directly activate ER-α in GC-1 cells (ER-β 
negative); this result has also been reported in 
JKT-1 cells (Bouskine et al. 2009). 
BPA-stimulated proliferation of GC-1 
cells is involved in activation of the GRP30. 
Recently, Sirianni et al. (2008) showed that 
GPR30, an orphan GPCR, mediates the 
proliferative effects induced by E2 in GC-1 
cells. Therefore, we examined whether both 
GPR30 and ER-α were involved in BPA’s pro-
motion of effects in GC-1 cells. We observed 
that the specific GPR30 agonist G1 and the 
ER-α agonist propyl pyrazole triol (PPT), but 
not the ER-β agonist DPN, stimulated GC-1 
cell proliferation [see Supplemental Material, 
Figure 5 (http://dx.doi.org/doi:10.1289/
ehp.1103781)]. Furthermore, we found that 
BPA plus G1 also induced the same effect as 
each of them alone, as was the case with BPA 
plus E2-BSA, indicating a similarity in the acti-
vated pathways. However, the combination of 
PPT and BPA or PPT and G1 exhibited even 
greater proliferative effects than did PPT, BPA, 
and G1 alone (PPT plus BPA, p = 0.024; PPT 
plus G1, p = 0.019) , suggesting that an addi-
tive or synergistic effect was possibly involved. 
These findings indicate that both GPR30 and 
ER-α were involved in proliferation of GC-1 
cells, which was also confirmed by Sirianni 
et al. (2008), and that cross-talk likely exists 
between these two proteins.
BPA phosphorylates the Ser118 site of ER-α 
by activating the GPR30 and EFGR-ERK 
pathways. Mitogen-activated protein kinase 
(MAPK)-mediated phosphorylation in Ser118 
site of ER-α has been suggested to enhance the 
tumor growth induced by MAPK/ER cross-
talk (Atanaskova et al. 2002). We wanted to 
know if BPA could phosphorylate the Ser118 
site of ER-α via such a mechanism. As shown 
in Supplemental Material, Figure 6 (http://
dx.doi.org/doi:10.1289/ehp.1103781), 10–9 M 
BPA markedly increased the levels of p-ser118-
ER-α (lane 2). However, the effects were com-
pletely abolished by the GPR30 antagonist G15 
(lane 4), EFGR inhibitor AG-1478 (lane 6), 
or MAPK inhibitor PD98059 (lane 8). These 
results demonstrate that BPA activates ER 
by phosphorylating ER-α, and this response 
is likely mediated through the GPR30 and 
EFGR-ERK pathways.
Silencing of Gpr30 and Ers-1 blocks BPA-
induced proliferation and fos expression in 
GC-1 cells. To further confirm the role that 
GPR30 and ER-α exert in BPA-induced 
proliferative effects of GC-1 cells, we investi-
gated cell proliferation by reducing Gpr30 and 
Ers‑1 expression by using AS-ODNs directed 
against these genes. The silencing of Gpr30 
and Ers‑1 expression by specific AS-ODNs 
significantly abolished GC-1 cell prolifera-
tion induced by E2, BPA, G1, and PPT with-
out altering either Ers‑1 expression or Gpr30 
(Figure 4A,B). Predictably, the antisense 
Gpr30 ODN could not completely suppress 
the proliferative effects of E2 and PPT, further 
suggesting that cross-talk between GPR30 and 
ER-α was involved with BPA-induced prolif-
eration of GC-1 cells.
GPR30 mediates rapid estrogen signal-
ing, leading to the induction of the activator 
protein-1 (AP-1) family member c‑fos (Sirianni 
et al. 2008), which participates in the regu-
lation of the cell cycle (Shaulian and Karin 
2002). As shown in Figure 4C and 4D, the 
AS-ODN completely blocked the expression of 
fos mRNA induced by E2, BPA, G1, and PPT 
without altering Ers‑1 or Gpr30 expression. 
The induction of c‑fos via GPR30 was 
previously demonstrated to occur after acti-
vation of EGFR and MAPKs (Sirianni et al. 
2008). As we predicted, both the EGFR 
inhibitor AG-1478 and the ERK inhibitor 
PD98059 significantly inhibited fos expres-
sion induced by E2, BPA, G1, and PPT [see 
Supplemental Material, Figure 7 (http://dx.doi.
org/doi:10.1289/ehp.1103781)]. In addition, 
we also observed that ICI markedly decreased 
BPA-mediated fos levels (see Supplemental 
Material, Figure 7), suggesting that ER-α parti-
cipated in the induction of BPA to fos.
Discussion
In this study we demonstrated that low concen-
trations of BPA (10–10 to 10–8 M) stimulated 
mouse spermatogonial proliferation of GC-1 
cells by activating both PKG and EFGR-ERK-
c-fos pathways mediated via cross-talk between 
GPR30 and ER-α.
Low concentrations of BPA have been 
reported to trigger a non  genomic prolifera-
tive effect in the pancreatic islet, endothe-
lium, breast, and pituitary gland by initiating 
rapid responses (Bulayeva and Watson 2004; 
Wetherill et al. 2007). In the present study, 
we also observed a representative non  genomic 
proliferative effect, which presented as the par-
adoxical inverse U-shaped curve, and rapid 
activation of CREB and Rb. Bouskine et al. 
(2009) demonstrated that low concentra-
tions of BPA promote proliferation in JKT-1 
human seminoma cells by activating PKA and 
PKG via a membrane GPCR. However, in 
our study, membrane GPCR, EFGR-ERK, 
and PKG pathways participated in the pro-
liferation of GC-1 cells stimu  lated by BPA. 
Transactivation of the EGFR and the ERK/
MAPK cascade promoted by the GPCR ago-
nist has been shown in a variety of cellular 
Figure 3. BPA did not directly transactivate ER-α in GC-1 and SkBr3 cells, as shown by firefly luciferase 
activity in GC-1 cells (A) and SkBr3 cells (B–D). (A) GC-1 cells transfected with the ER luciferase reporter 
plasmid ERE-luc (XETL) and treated with E2 or BPA (each at 10–9 M), with or without ICI. (B–D) SkBr3 cells 
transfected with ER luciferase reporter gene XETL and ER-α expression plasmid (B), with Gal4 reporter 
gene (GK1) and the Gal4 fusion proteins encoding the HBD of ER (GalER-α; C), and with GK1 and GalER-β (D) 
and treated with E2 or BPA (each at 10–9 M), with and without ICI. See “Materials and Methods” for details. 
Luciferase activity was normalized to Renilla luciferase expression vector (pRL-TK), and the value for 
vehicle-treated cells was set as 1-fold induction. Values shown (mean ± SE) represent the results of three 
independent experiments performed in triplicate. 
*p < 0.05, compared with control. **p < 0.05, compared with E2. 
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contexts. Again, estrogenic activation of the 
ERK/CREB pathway via a GPCR has already 
been demonstrated in several models (Belcher 
et al. 2005; Filardo 2002).
We observed that ER-α was involved 
in BPA’s activity because gene silencing and 
antagonism of ER-α significantly suppressed 
BPA-stimulated proliferation of GC-1 cells. 
However, the activation of ER-α was not 
through its direct binding with BPA in the gene 
reporter assay, but it was phosphorylated at its 
Ser118 site. ER-α contains both hormone-
independent and hormone-inducible transacti-
vation functions (AF-1 and AF-2, respectively) 
(Metzger et al. 1995). Hormone-independent 
activation of ER-α by growth factors leads to 
phosphorylation of Ser118 located within AF-1 
(Joel et al. 1995). Because many growth factor 
pathways converge on MAPK, it is thought 
that MAPK-mediated phosphorylation of AF-1 
represents a mechanism whereby MAPK/ER 
cross-talk enhances ER-α–mediated signaling 
and tumor growth (Atanaskova et al. 2002). 
Several lines of evidence have suggested that 
the inter  action of EGFR-MAPK with estrogen 
signaling can occur at different levels (Filardo 
et al. 2000; Levin 2003). Indeed, our study 
reveals that BPA phosphorylates ER-α by 
EFGR-ERK–dependent pathways.
An unknown GPCR has been suggested 
to mediate the BPA-stimulated prolifera  tion 
of GC-1 cells because of the suppression of 
the Gαi/Gαq inhibitor PTX and promotion 
of E2-BSA, an impermeable E2 conjugate. 
Recently, GPR30, a trans  membrane estrogen-
binding orphan GPCR, has been shown to 
potentially mediate rapid E2-dependent pro-
liferation in cancer cells (Albanito et al. 2007; 
Filardo 2002; Revankar et al. 2005). A variety 
of environmental contaminants exhibit bind-
ing affinities for GPR30 as well as agonist 
activities similar to those for ER (Thomas and 
Dong 2006). The present data indicate that 
GPR30 is required for this proliferation-pro-
moting response and for indirect activation of 
ER-α phosphorylation by BPA.
c-fos represents a prototypical early gene, 
and its encoded nuclear protein regu  lates the 
expression of genes involved in proliferation, 
invasion, differentiation, and cell survival 
(Shaulian and Karin 2002). The present study 
indicates that BPA induces fos gene expression 
by the activation of GPR30, EFGR-ERK, and 
ER-α. GPR30 expression is induced through 
an EGFR-MAPK-c‑fos pathway by recruit-
ing c‑fos to the AP-1 site of the GPR30 gene, 
aggravating GPR30 and c‑fos expression via a 
regulatory loop (Albanito et al. 2008b). Thus, a 
significant increase (3- to 5-fold) in fos expres-
sion after the various treatments observed in 
the present study will assuredly bolster the 
BPA-induced proliferation of GC-1 cells, 
because the subtle change in fos gene expression 
equated to profound pheno  typic effects.
Estrogens acting via GPR30 are capable 
of stimulating adenylyl cyclase activity, which 
in turn leads to PKA-mediated suppression 
of EGFR-ERK (Filardo et al. 2002). Our 
results suggest that PKA possibly did not par-
ticipate in the suppression of this pathway 
because inhibition of PKA activation could 
not enhance the prolifera  tive effects of BPA. 
Thus, we assumed that BPA-induced pro-
lifera  tion of GC-1 cells via GPR30 was likely 
to be long-lasting because of the lack of the 
opposing effects on the EGFR-to-MAPK axis. 
Hence, data from the present study indi-
cate that a complex interplay between ER-α 
and GPR30 contributes to low concentrations 
of BPA activity in GC-1 cells by activating 
EGFR-ERK transduction pathways, simi-
lar results for atrazine in ovarian cancer cells 
(Albanito et al. 2008a; Bunone et al. 1996). 
Based on the present data and available lit-
erature, BPA may act via GPR30 to activate 
PKG and induce the release of surface-bound, 
membrane-anchored, heparin-binding, EGF-
like growth factor (proHB-EGF) (Filardo 
et al. 2000), which in turn activates EFGR-
ERK/ER-α/c‑fos pathways, finally leading to 
the stimulation of a mitogenic signaling net-
work (Bunone et al. 1996; Lannigan 2003). 
ER-β participates in the control of pro-
liferation and/or apoptosis of male germ cells 
just after birth, and its down-regulation is 
strongly correlated with human testicular semi-
nomas (Hirvonen-Santti et al. 2003; Pais et al. 
2003). Therefore, it has been assumed that 
human gonocytes, which do not express the 
active ER-β1 isoform until the pre  natal period 
(Gaskell et al. 2003), may be exclusively sensi-
tive to the BPA-mediated promoting effect. 
Thus, the exposure of the fetuses to BPA likely 
poses a hazard to male germ cells. In a group of 
pregnant mothers and their fetuses, Schönfelder 
et al. (2002) observed blood BPA levels of   
0.3–18.9 ng/mL (1.31 × 10–9 to 8.28 × 
10–8 M) and 0.2–9.2 ng/mL (8.76 × 10–10 
to 4.29 × 10–8 M), respectively; based on 
prior studies (Welshons et al. 2006), these 
levels equate to similar concentrations used 
in the present study. This implies that expo-
sure of pregnant mothers to low BPA levels 
may exert adverse biological effects on fetuses. 
Thus, excessive fetal exposure to xeno  estrogens 
with high affinity for the non  classical estrogen 
GPCR (e.g., GPR30), such as shown here for 
BPA, may stimulate abnormal non  genomic 
prolifera  tion of gono  cytes, consequently result-
ing in malignant germ cell transformation/
carcinoma in situ and then testicular germ cell 
cancer, the most frequent cancer of young 
men, with increasing incidence.
The primary focus of our study was on an 
in vitro approach to investigate the molecular 
mechanisms of BPA action. However, it is 
Figure 4. Silencing of Gpr30 or Ers-1 inhibited BPA-induced cell proliferation (A, B) and fos gene expres-
sion (C, D) in GC-1 cells transfected with control scrambled (CS)-ODN and GPR30/AS-ODN (A, C) or with 
CS-ODN and Ers-1/AS-ODN (B, D) and treated with E2 (10–9 M), BPA (10–9 M), G1, PPT, or DPN (each at 
10–7 M). Cell proliferation was determined by MTT assay (A, B), and fos mRNA levels were examined with 
real-time RT-PCR (C, D), as described in “Materials and Methods.” Values shown (mean ± SE) represent 
results of three independent experiments performed in triplicate; the control value was set as 1. 
*p < 0.05, compared with control. **p < 0.05, compared with E2. #p < 0.05, compared with BPA. ##p < 0.05, compared with 
G1. †p < 0.05, compared with PPT. 
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critically important to consider combining 
in vitro and in vivo approaches to investigate 
actions of BPA at exposures mirroring those 
that occur in human and animal populations. 
Thus, in future research, we will extend our 
in vitro experiments to an in vivo study using 
rats chronically exposed to environmentally 
relevant concentrations of BPA.
In conclusion, our results provide a novel 
insight regarding the potential role of GPR30 
and ER-α in mediating a growth stimulatory 
action of low concentrations of BPA in male 
germ cells.
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